Best Agrolife Ltd

Best Agrolife Ltd

₹ 600 2.05%
22 Nov 10:30 a.m.
About

Best Agrolife (formerly known as Sahyog Multibase Limited) [1] is a leading agrochemicals manufacturer in India and is among the top 15 agrochemicals companies in the country. It is one of the fastest growing manufacturers of Technicals, Formulations, Intermediates and Public Health products. Best Agrochem Private Limited was amalgamated with the Co. in April 2018.

It offers more than 70 Formulations in the form of Insecticides, Herbicides, Fungicides and Plant Growth Regulators, which are developed from active ingredients manufactured in-house. As part of its P2P set-up, Best Agrolife caters to several blue-chip corporates and leading MNCs from India and abroad. [2]

Key Points

Product Portfolio
The Co has three business activities namely, Technical, Formulation, and Branded Products. [1]
The product profile includes insecticides, pesticides, herbicides, plant-growth regulators (PGR) and biocides. As of Q2FY24, it has licence of 250+ formulations registered with Central Insecticide Board (CIB), PGRs and bio fertilizers. As of FY23, it has 60+ products, 80+ technical licenses, 360+ formulation licenses.Some of its best selling products are DIRON, PYMAX, PYDON, IRMA, etc. [2] It launched key products like RONFEN, AXEMAN, REVEAL, CITIGEN, and VISTARA. [3][4]

  • Market Cap 1,419 Cr.
  • Current Price 600
  • High / Low 918 / 454
  • Stock P/E 51.3
  • Book Value 177
  • Dividend Yield 0.49 %
  • ROCE 9.13 %
  • ROE 3.71 %
  • Face Value 10.0

Pros

  • Company's median sales growth is 30.3% of last 10 years

Cons

  • Company has low interest coverage ratio.
  • Dividend payout has been low at 8.59% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
324 207 258 423 579 238 260 613 734 348 104 361 434
289 184 228 390 513 216 295 576 690 349 121 321 371
Operating Profit 35 23 31 34 66 22 -35 36 44 -1 -17 40 63
OPM % 11% 11% 12% 8% 11% 9% -14% 6% 6% -0% -16% 11% 15%
0 1 3 3 4 1 1 5 -2 2 2 2 2
Interest 2 3 5 4 6 6 8 8 11 14 10 11 11
Depreciation 1 1 1 1 1 1 2 1 2 2 2 2 2
Profit before tax 33 20 28 31 63 16 -43 32 30 -15 -28 30 52
Tax % 25% 26% 24% 25% 26% 42% -25% 26% 26% -24% -24% 25% 27%
25 15 22 23 47 9 -32 24 22 -12 -21 22 38
EPS in Rs 11.32 6.25 9.12 9.93 19.81 3.89 -13.72 10.11 9.38 -4.88 -8.92 9.31 16.19
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
0 0 -0 9 99 129 663 690 905 1,134 1,500 1,798 1,247
0 0 0 9 98 132 652 675 854 1,009 1,414 1,736 1,162
Operating Profit 0 -0 -0 -0 1 -3 11 15 51 125 86 62 85
OPM % 25% -57% -2% 1% -2% 2% 2% 6% 11% 6% 3% 7%
-0 0 0 0 0 4 2 4 7 5 10 6 7
Interest -0 -0 -0 -0 1 1 5 6 5 11 24 43 46
Depreciation -0 -0 -0 -0 0 0 1 2 3 4 5 7 7
Profit before tax 0 0 0 0 0 0 7 12 51 116 67 19 39
Tax % 50% 33% 20% 43% 567% 175% 36% 29% 27% 25% 30% 30%
0 0 0 0 -0 -0 5 8 37 87 47 13 28
EPS in Rs 0.03 0.07 0.10 0.13 -0.46 -0.07 5.88 10.36 16.83 36.82 19.91 5.69 11.70
Dividend Payout % -0% -0% -0% 76% -57% -399% -0% 3% 12% 5% 15% 5%
Compounded Sales Growth
10 Years: 176%
5 Years: 22%
3 Years: 26%
TTM: -32%
Compounded Profit Growth
10 Years: 92%
5 Years: 30%
3 Years: -29%
TTM: 21%
Stock Price CAGR
10 Years: %
5 Years: 19%
3 Years: -22%
1 Year: -32%
Return on Equity
10 Years: 14%
5 Years: 17%
3 Years: 16%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 3 3 3 3 8 8 22 22 22 24 24 24 24
Reserves -0 -0 0 0 41 43 156 62 108 289 336 342 396
-0 -0 -0 -0 -0 8 39 35 32 137 286 348 330
2 3 0 1 38 22 265 217 209 260 283 443 486
Total Liabilities 5 6 3 4 87 81 482 336 371 709 928 1,157 1,235
-0 -0 -0 -0 0 0 110 15 19 21 33 32 32
CWIP -0 -0 -0 -0 -0 -0 -0 -0 0 -0 0 1 1
Investments -0 0 0 0 26 3 4 5 0 102 102 116 121
5 6 3 4 60 78 369 315 352 586 793 1,007 1,081
Total Assets 5 6 3 4 87 81 482 336 371 709 928 1,157 1,235

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 0 0 -0 -13 -35 60 16 10 -0 -128 -35
-0 -0 0 0 -36 25 -5 -5 12 -97 55 -20
-0 -0 -0 -0 48 11 -45 -13 -12 90 118 12
Net Cash Flow -0 0 0 0 -0 0 11 -3 10 -8 45 -42

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days -0 -0 88 72 86 112 92 53 75 73 66
Inventory Days -0 31 31 43 42 67 77 90 86
Days Payable 75 53 141 101 72 82 63 83
Cash Conversion Cycle -0 -0 88 29 63 14 33 48 70 100 69
Working Capital Days 13,688 15,486 111 76 156 30 39 44 93 98 97
ROCE % 1% 1% 2% 2% 5% -2% 8% 11% 40% 41% 17% 9%

Shareholding Pattern

Numbers in percentages

3 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
45.42% 45.42% 47.30% 47.30% 48.20% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10%
11.22% 11.31% 10.82% 11.27% 12.05% 11.48% 10.84% 9.86% 8.86% 8.77% 8.73% 8.03%
0.19% 0.20% 0.20% 2.57% 2.57% 2.58% 2.55% 2.63% 2.53% 2.53% 2.53% 2.67%
43.17% 43.08% 41.68% 38.86% 37.16% 35.84% 36.50% 37.42% 38.50% 38.60% 38.62% 39.18%
No. of Shareholders 4,9528,2258,76011,36021,20623,03927,20031,94037,57139,86141,57040,573

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls